Sphingosine 1-phosphate signaling in uterine fibroids: implication in activin A pro-fibrotic effect
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This paper investigates the role of sphingosine 1-phosphate signaling in uterine fibroids and its potential involvement in the pro-fibrotic effects of activin A.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo explore the link between sphingosine 1-phosphate (S1P) signaling and leiomyoma and the possible S1P cross-talk with the fibrotic effect of activin A.DesignCase-control laboratory study.SettingUniversity institute and university hospital.Patient(s)Patients with uterine fibroids (n = 26).Interventions(s)Tissue specimens of leiomyoma and normal myometrium were obtained from patients undergoing myomectomy or total hysterectomy.Main outcome measure(s)Expression of mRNA levels of the enzyme involved in S1P metabolism, S1P receptors, and S1P transporter Spns2 was evaluated in matched leiomyoma/myometrium specimens and cell populations. The effects of inhibition of S1P metabolism and signaling was evaluated on activin A-induced fibrotic action in leiomyoma cell lines.Result(s)The expression of the enzymes responsible for S1P formation, sphingosine kinase (SK) 1 and 2, and S1P2, S1P3, and S1P5 receptors was significantly augmented in leiomyomas compared with adjacent myometrium. In leiomyoma cells, but not in myometrial cells, activin A increased mRNA expression levels of SK1, SK2, and S1P2. The profibrotic action of activin A was abolished when SK1/2 were inhibited or S1P2/3 were blocked. Finally, S1P augmented by itself mRNA levels of fibrotic markers (fibronectin, collagen 1A1) and activin A in leiomyomas but not in myometrial cells.Conclusion(s)This study shows that S1P signaling is dysregulated in uterine fibroids and involved in activin A-induced fibrosis, opening new perspectives for uterine fibroid treatment.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β–induced fibrosis 2020
- [Histological and biochemical studies of collagen in human uterine leiomyomas]. 1985
Cited by (2)
References (59)
- [Histological and biochemical studies of collagen in human uterine leiomyomas]. via openalex
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure via openalex
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β–induced fibrosis via openalex
- doi:10.1016/j.tcb.2011.09.003 via openalex
- doi:10.1038/nprot.2008.73 via openalex
- doi:10.1006/meth.2001.1262 via openalex
- doi:10.1177/1933719114542019 via openalex
- doi:10.1194/jlr.m800496-jlr200 via openalex
- doi:10.1016/j.biochi.2019.01.018 via openalex
- doi:10.21037/tcr.2017.10.05 via openalex
- doi:10.1016/j.ajpath.2017.06.017 via openalex
- doi:10.1016/j.bbamcr.2018.12.007 via openalex
- doi:10.1055/s-0030-1251475 via openalex
- doi:10.1038/nrd3248 via openalex
- doi:10.1126/science.1112063 via openalex
- doi:10.1093/humupd/dmx032 via openalex
- doi:10.1111/j.1365-2265.2008.03207.x via openalex
- doi:10.1371/journal.pone.0182329 via openalex
- doi:10.3390/ijms19051498 via openalex
- doi:10.1016/j.cellsig.2008.10.007 via openalex
- doi:10.1016/j.fertnstert.2016.01.032 via openalex
- doi:10.1016/j.bpobgyn.2015.11.015 via openalex
- doi:10.1007/978-3-030-21162-2_7 via openalex
- doi:10.1136/thoraxjnl-2011-200026 via openalex
- doi:10.1385/1-59259-372-0:69 via openalex
- doi:10.1126/science.aar5551 via openalex
- doi:10.1074/jbc.m109.068395 via openalex
- doi:10.1016/j.cellsig.2018.02.001 via openalex
- doi:10.3389/fimmu.2017.01242 via openalex
- doi:10.1038/srep32119 via openalex
- doi:10.3390/ijms21062064 via openalex
- doi:10.1016/j.ijrobp.2006.08.058 via openalex
- doi:10.3389/fphys.2013.00338 via openalex
- W6717593941 via openalex
- doi:10.1016/j.ab.2012.10.010 via openalex
- doi:10.1016/j.bbalip.2012.06.013 via openalex
- doi:10.1002/1878-0261.12048 via openalex
- doi:10.1038/s41598-019-47048-0 via openalex
- doi:10.3389/fphar.2018.01504 via openalex
- doi:10.1055/s-0037-1607265 via openalex
- doi:10.1016/j.cellsig.2011.07.010 via openalex
- doi:10.1186/1748-717x-4-66 via openalex
- doi:10.1016/j.jhep.2013.02.021 via openalex
- doi:10.1016/j.fertnstert.2013.03.007 via openalex
- doi:10.1177/1933719115592710 via openalex
- doi:10.1210/jc.2013-2623 via openalex
- doi:10.1007/s00441-015-2324-3 via openalex
- doi:10.1016/j.fertnstert.2004.04.030 via openalex
- doi:10.1055/s-0030-1251476 via openalex
- doi:10.1210/jc.2010-0501 via openalex
- doi:10.1681/asn.2016030306 via openalex
- doi:10.1096/fj.13-228528 via openalex
- doi:10.1016/j.fertnstert.2014.05.013 via openalex
- doi:10.1210/en.2006-0291 via openalex
- doi:10.3390/ijms19010139 via openalex
- doi:10.1091/mbc.e09-09-0812 via openalex
- doi:10.1084/jem.20110551 via openalex
- doi:10.3109/14767058.2014.921675 via openalex
- doi:10.1016/j.bpobgyn.2015.08.018 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-14T06:20:05.154166+00:00
License: CC0
· commercial use OK